Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Abbott - Caught on Camera

Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?

Despite Abbott Laboratories' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Barchart

Diabetes Wearable Cleared for Children as Young as Two Tracks Ketones and Blood Sugar from One Sensor

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking ketones and glucose together, for people with diabetes aged 2 and up.

Medical Daily

Abbott Stock: Is Wall Street Bullish or Bearish?

Abbott has lagged behind the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

New blood test to detect colon cancer clears FDA approval

New cases of colorectal cancer and deaths have been rising in younger adults since the mid-2000s

The Independent UK

FDA Approves a Blood Test for Colorectal Cancer Screening That Misses Most Precancerous Growths

The FDA approved SimpleScreen CRC, a blood test for colorectal cancer screening. It detects cancer well but finds few precancerous lesions.

Medical Daily

This Dividend King Could Be One of the Safest Stocks to Own Right Now

Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock.

Barchart

Trump DOJ Drops Corporate Crime Investigations, Giving Major Companies a Free Pass

The Trump Justice Department has dropped several high-profile corporate investigations, including an inquiry into Federal Reserve Chair Jerome Powell, fueling concerns over a pullback in enforcement.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street

Abbott's Q2 results show solid organic growth, better-than-expected margins, and improved earnings guidance, easing concerns over the Exact Sciences acquisition and boosting ABT shares.

MarketBeat

Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised

Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.

The Economic Times

Infant Formula Makers Were Required to Tell the FDA When Babies Died — Records Show They Never Did

KFF Health News found the FDA received zero formula maker death notifications going back to 2000. Abbott's expert testified it never reported a single death for preterm formula.

Medical Daily

Premature Infants in NICUs Face a Higher Risk of NEC from Formula, Experts Warn

If your premature baby is in the NICU on cow's milk formula, ask about NEC risk now. Here are the specific questions to ask your neonatologist and what the evidence shows.

Medical Daily

Abbott Laboratories Federal Formula Safety Probe Quietly Shelved Following Massive Cash Injection To Donald Trump Fund

The US Justice Department has ended its criminal investigation into Abbott Laboratories' contaminated baby formula plant, opting for civil penalties instead, amid scrutiny over political donations.

International Business Times UK

DOJ Dropped Secret Criminal Charges Against Baby Formula Giant Abbott Despite Claims Contaminated Milk 'Sickened And Killed' Infants

The Justice Department has closed its criminal investigation into Abbott Laboratories, opting for civil penalties over charges related to the 2022 baby formula contamination and shortage.

International Business Times UK

Abbott Laboratories' Q2 2026 Earnings: What to Expect

Abbott Laboratories is scheduled to report its second-quarter results in July, and analysts expect a single-digit earnings rise.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Android Central

Ultrahuman seeks to define: M2 Live keeps your metabolic health close with a small sensor

Ultrahuman launches M2 Live with Abbott's Lingo biosensor to help users take their glucose (metabolic health) more seriously with a continuous monitor.

TechRadar

Hate giving blood? Samsung’s latest VR demo will help you meditate while donating — and it’s given me some ideas

Samsung’s XR headset might help you relax the next time you give blood, thanks to VR meditation.

MarketBeat

MiniMed Group Q4 Earnings Call Highlights

MiniMed Group (NASDAQ:MMED) reported record fiscal 2026 revenue and outlined a slate of product launches it said will support faster growth in fiscal 2027, as management held the company’s first earnings call as a standalone public company following its March IPO. Chief Executive Officer Que Dallar

Barchart

3 Ultra-Reliable Dividend Kings Trading at Bargain-Basement Prices

These beaten-down Dividend Kings, trading near their 2026 lows, offer income, rebound potential, and Wall Street-backed upside for patient investors.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity

While ABT stock appears poised to reach the year’s halfway mark in ignominy, the options market is quietly signaling a possible recovery.

Fortune

Gen X is the most indebted generation in America. Their employers can fix that

Student loan matching programs are on the books. Does your company have one?

MarketBeat

Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell

See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors.

The Guardian - US

What to know about Kyle Diamantas, the new acting FDA commissioner

The ex-lawyer who Trump described as ‘very talented’ was previously deputy commissioner for food at the FDA

Barchart

Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend Payer

Abbott’s business and dividend story remain intact even as the stock trades near 52‑week lows.

The Independent UK

FDA finds US infant formula supply is ‘safe’ after examining 300 samples in Operation Stork Speed

The review was conducted as part of the Food and Drug Administration’s Operation Stork Speed project

The Independent UK

US infant formula supply is 'safe,' FDA says after looking for potential contaminants

Federal health officials said a new analysis of U.S. infant formula found reassuringly low levels of heavy metals, pesticides and other potential contaminants

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.